Emergent BioSolutions | Devedores Comerciais



Trade Debtors Alterar Data
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
ALKERMES USD 321.75M 72.97M 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amarin USD 106.73M 15.54M 2025-03
ANI Pharmaceuticals USD 220.33M 1.39M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Exact Sciences USD 279.8M 30.83M 2025-03
Exelixis USD 281.64M 16.2M 2025-04
Glaxosmithkline GBP 7.32B 542M 2024-12
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Lonza CHF 1.33B 269M 2024-12
Merck USD 11.57B 452M 2025-03
Moderna USD 306M 286M 2025-03
Myriad Genetics USD 120.4M 800K 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Pacira USD 104.74M 8.56M 2025-03
Pfizer USD 14.74B 32M 2025-03
PTC Therapeutics USD 210.5M 51.94M 2025-03
Sanofi 447M 10.18B 2025-03
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
United Therapeutics USD 322M 42.7M 2025-03



Emergent BioSolutions Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.